James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 11,894 shares at $22.50 ($268K) on 2023-05-17, disclosed to the SEC on 2023-05-19.
Open-market sale of $268k ACAD by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 5,947 | $134K | 50.0% |
| 2 | $22.50 | 5,947 | $134K | 50.0% |
| Total | $22.50 avg | 11,894 | $268K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |